OncoMed Pharmaceuticals Inc (NASDAQ:OMED) - Overview

Stock Report

OncoMed Pharmaceuticals Inc OMED

Last Price
$8.48

Day Change
0.26|3.16%

As of 02/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close8.22
Day Range8.20 - 8.73
Mkt Cap314.50Mil
52-Wk Range8.07 - 23.98
Yield %-
ISINUS68234X1028
Volume104,370
P/E-2.50
P/S10.24
P/CF-8.29

Share Price

Financials
201320142015
More ...
Income Statement
Revenue37.7839.5625.90
Operating Income-23.90-50.62-85.56
Net Income-26.07-50.01-85.41
Basic EPS-1.93-1.69-2.84
Avg. Diluted Shares Outstanding143030
Balance Sheet
Current Assets318.74240.81231.26
Non Current Assets14.947.036.63
Total Assets333.69247.84237.89
Current Liabilities62.0238.5552.64
Total Liabilities215.56171.48234.34
Total Equity118.1276.373.55
Cash Flow
Operating Cash Flow144.54-84.51-75.14
Capital Expenditure-0.56-1.81-1.36
Free Cash Flow143.99-86.32-76.50

In millions, except "Basic EPS". Currency is USD.

Company Profile

OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology product candidates.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

122
Key Stats
More ...
Price/Earning TTM-2.42
Price/Book-95.80
Price/Sales TTM10.11
Rev Growth (3 year avg)1.62
EPS Growth (3 year avg)-
Operating Margin % TTM-330.35
Net Margin % TTM-329.77
ROE TTM-213.74
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.